- Exchange: OTC BB
- Sector: Materials
- Industry: Chemicals
- Sub-Industry: Specialty Chemicals
Arch Therapeutics Inc+ Add to Watchlist
ARTH:US0.1950 USD 0.0200 11.43%
As of 20:10:00 ET on 12/11/2013.
Company Profile for Arch Therapeutics Inc (ARTH)
Arch Therapeutics, Inc. operates as a life science company developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding.
Arch Therapeutics Inc
Key Executives for Arch Therapeutics Inc (ARTH)
|Avtar S DhillonChairman||Terrence W NorchiPresident/CEO|
|Alan T BarberChief Financial Officer||William M Cotter "Bill"Chief Operating Officer|